Shares of DexCom Inc. DXCM slipped 1.72% to $66.14 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.81% to 5,363.36 and ...

As the sun beat down on the eve of another sunny weekend in Drury Street in Dublin, revellers on the street were in high spirits. Beaming from ear to ear, they danced to live music and clutched ...

San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems. Valued at $26.2 billion by ...

In a report released today, Matt Miksic from Barclays maintained a Hold rating on Dexcom (DXCM – Research Report), with a price target of $90.00. The company’s shares closed yesterday at $67.30.

Dexcom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, Dexcom has captured an impressive slice ...

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA clearance on April 10 for adults with ...

April 9 – June 1, 2025 Conspiracy, Secrets, and the Holy Grail Witness the action-packed novel live on stage as Professor Robert Langdon and cryptologist Sophie Neveu race against the clock to ...

She is also a Certified Stress Management Coach. The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes.

The Food and Drug Administration (FDA) has cleared diabetes-management firm DexCom's (DXCM) new continuous glucose monitoring (CGM) system. The San Diego, Calif.-based firm said Thursday that its ...

SPRINGFIELD, Mo. — Drury University is holding their fourth annual Fusion Day in recognizing students work. Over 300 students will present their original work to their colleagues and people ...

FDA clears Dexcom G7 15-Day CGM for adults, offering 15.5 days of wear and a MARD of 8.0% for improved diabetes management. New features include Apple Watch connectivity, medication logging ...

DexCom shares rose in premarket trading Thursday morning after the company said it received regulatory clearance in the U.S. for its diabetes monitoring system. Shares traded 8.5% higher at $72.55 ...